Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Efletirizine
Cat. No.:
OB0225LY-0115
Appearance:
Oil
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Efletirizine is a histamine receptor antagonist that inhibits 5-lipoxygenase.
Synonym:
UCB 28754; UCB-28754; UCB28754; 150756-35-7; Efletirizine [INN]; 2-[2-[4-[Bis(4-fluorophenyl)methyl]piperazin-1-yl]ethoxy]acetic acid; (2-(4-(Bis(p-fluorophenyl)methyl)-1-piperazinyl)ethoxy)acetic acid; 2-(4-(Bis(4-fluorophenyl)-methyl-1-piperazinyl)ethoxy)acetic acid; Acetic acid, 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]-
CAS No.:
150756-35-7
Compound CID:
66003
Formula:
C21H24F2N2O3
Formula Weight:
390.42
Specification
Relative Density:
1.256 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Efletirizine can be used for allergy research.
Library Information
Targets:
Histamine receptor; Lipoxygenase
Receptors:
Histamine receptor; 5-Lipoxygenase
Pathways:
Immunology/Inflammation; Neuronal signaling; GPCR/G protein; Metabolism
Plate Number:
AOCL-2
Plate Location:
d8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 153.68 mM
